While semaglutide is best known as the active ingredient in injectable medications like Wegovy, its also the active ingredient in newer sublingual (under the tongue) GLP-1 medications
Clinical trials also show that Wegovy helps 83.5% of people lose at least 17% of their body weight over 68 weeks on 2.4mg, which could have wider benefits for your health, including your heart and circulatory system
Solution: Always inject air equal to your dose volume before drawing
Results vary based on individual health, adherence to treatment, and lifestyle factors
However, because Wegovy is also approved to reduce the risk of major cardiovascular events (heart attack, stroke, death), Medicare coverage may be available if your provider prescribes it under that indication
1 2 Adverse Drug Reactions